Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
8.60
+0.03 (0.35%)
Feb 3, 2026, 1:25 PM CST
11.83%
Market Cap16.66B +10.9%
Revenue (ttm)2.74B +12.7%
Net Income1.23B +259.2%
EPS0.63 +292.9%
Shares Out1.94B
PE Ratio13.67
Forward PE19.37
Dividend0.25 (2.76%)
Ex-Dividend DateJun 25, 2025
Volume21,096,115
Average Volume35,983,828
Open8.61
Previous Close8.57
Day's Range8.56 - 8.77
52-Week Range7.00 - 9.67
Beta0.30
RSI45.42
Earnings DateApr 20, 2026

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metfor... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements